about
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's candidate, cretostimogene grenaden...
Read More
26.91
0.87
(3.34%)
1.2M
XNAS Volume
XNAS 30 Jul, 2025 4:02 PM (EDT)
Board Meeting
The next board meeting for Cg Oncology Inc. is on 08 Aug 2025 for the purpose of CG Oncology Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Cg Oncology Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..